Study on the correlation between the risk of thrombosis and bleeding after the treatment of spinal metastatic tumor and the effect of anticoagulation

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2100042058

Enrollment

Unknown

Registered

2021-01-13

Start date

2021-01-10

Completion date

Unknown

Last updated

2021-04-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

spinal tumor,VTE

Interventions

1: NO anticoagulation treatment

2:use of low molecular heparin during operation

3:use of low molecular heparin 3 days after operation

4:use of low molecular heparin one week after operation

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: (1) Aged less than 80-year-old; (2) diagnosis of spinal neoplasm; (3) neurological deficit due to spinal neoplasm.

Exclusion criteria

Exclusion criteria: (1) Intradural metastases; (2) more than 8 scores in Tomita Score; (3) health too poor to undergo surgery; (4) diagnosis of heart or respiratory failure.

Design outcomes

Primary

Measure	Time frame
Thrombotic event;Bleeding event;Drainage;clotting time;Intracaspinal hematoma;	—

Secondary

Measure	Time frame
Skin ecchymosis area;Serum albumin;	—

Countries

China

Contacts

Public ContactJianru Xiao

Department of Orthopedic Oncology, Changzheng Hospital, Navy Medical University

jianruxiao83@163.com+86 13701785283

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026